ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Ophthalmology

Top Ophthalmology Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS GRAUL M.D.

Ophthalmology

5,060

$378K

587
533 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 63%

$75
Average prescription price

Avg: $61

MARTIN MIZENER MD

Ophthalmology

4,944

$264K

696
645 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 63%

$53
Average prescription price

Avg: $61

GREGORY SUTTON MD

Ophthalmology

4,890

$171K

1029
963 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 63%

$35
Average prescription price

Avg: $61

MAX LINDER M.D.

Ophthalmology

3,524

$151K

843
802 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 63%

$43
Average prescription price

Avg: $61

PAUL DIETZE MD

Ophthalmology

3,422

$152K

679
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 63%

$45
Average prescription price

Avg: $61

ROBERT PROFFITT M.D.

Ophthalmology

3,157

$230K

635
605 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

72%
prescriptions for brand name drugs

Avg: 63%

$73
Average prescription price

Avg: $61

LORI HARKINS M D

Ophthalmology

3,040

$227K

466
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 63%

$75
Average prescription price

Avg: $61

SAO LIU M.D.

Ophthalmology

3,040

$207K

676
621 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

79%
prescriptions for brand name drugs

Avg: 63%

$68
Average prescription price

Avg: $61

SAO LIU M.D.

Ophthalmology

2,768

$210K

713
642 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

83%
prescriptions for brand name drugs

Avg: 63%

$76
Average prescription price

Avg: $61

THOMAS ROUSSEL M.D.

Ophthalmology

2,760

$139K

604
581 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

72%
prescriptions for brand name drugs

Avg: 63%

$50
Average prescription price

Avg: $61

CAMILLA PARSON MD

Ophthalmology

2,699

$123K

492
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 63%

$46
Average prescription price

Avg: $61

ANNE FITZPATRICK M.D.

Ophthalmology

2,446

$220K

441
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

67%
prescriptions for brand name drugs

Avg: 63%

$90
Average prescription price

Avg: $61

FREDERICK MAUSOLF MD

Ophthalmology

2,257

$113K

450
425 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 63%

$50
Average prescription price

Avg: $61

THOMAS CLINCH MD

Ophthalmology

2,197

$154K

535
492 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

81%
prescriptions for brand name drugs

Avg: 63%

$70
Average prescription price

Avg: $61

SUSHMA RAI M.D.

Ophthalmology

2,170

$161K

282
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

68%
prescriptions for brand name drugs

Avg: 63%

$74
Average prescription price

Avg: $61

RAYMOND CROSSMAN M.D.

Ophthalmology

2,150

$142K

337
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 63%

$66
Average prescription price

Avg: $61

GREGORY HASKINS MD

Ophthalmology

2,119

$117K

502
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 63%

$55
Average prescription price

Avg: $61

VINCENT SUTTON M.D.

Ophthalmology

2,094

$66.1K

605
565 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 63%

$32
Average prescription price

Avg: $61

STEVEN SAMUELSON MD

Ophthalmology

1,944

$122K

410
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 63%

$63
Average prescription price

Avg: $61

MICHAEL HALSTED MD

Ophthalmology

1,765

$86.2K

472
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

70%
prescriptions for brand name drugs

Avg: 63%

$49
Average prescription price

Avg: $61

JULIE JANKY M.D.

Ophthalmology

1,672

$104K

386
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 63%

$62
Average prescription price

Avg: $61

JOSEPH TOWNLEY MD

Ophthalmology

1,609

$134K

433
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

77%
prescriptions for brand name drugs

Avg: 63%

$83
Average prescription price

Avg: $61

JUDSON MARTIN M.D.

Ophthalmology

1,600

$72.4K

348
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 63%

$45
Average prescription price

Avg: $61

MARK YOUNG M.D.

Ophthalmology

1,532

$138K

369
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

89%
prescriptions for brand name drugs

Avg: 63%

$90
Average prescription price

Avg: $61

SHAWNA COLLIER M.D.

Ophthalmology

1,528

$73.6K

358
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

66%
prescriptions for brand name drugs

Avg: 63%

$48
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank